SCHEMBL28110012

SCHEMBL28110012

Cc1ncsc1C(OC=O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 2/20 0.42
HTT P42858 2/20 0.35
ADRA1A P35348 3/20 0.33
HTR1A P08908 2/20 0.33
ADRA1D P25100 2/20 0.33
ADRA1B P35368 2/20 0.33
KDM4E B2RXH2 2/20 0.33
PKM P14618 1/20 0.33
SCN1A P35498 3/20 0.31
SCN2A Q99250 3/20 0.31
SCN3A Q9NY46 3/20 0.31
LMNA P02545 2/20 0.31
CYP1A2 P05177 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
CHRM5 P08912 1/20 0.31
ADRA2A P08913 1/20 0.31
CYP2D6 P10635 1/20 0.31
CHRM1 P11229 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9025932 0.81 SLC6A3 (0.42) SLC6A3HTTADRA1AKDM4EPKM
SCHEMBL8630959 0.78 ALDH1A1 (0.41) SLC6A3KDM4EPKMTSHRGLS
SCHEMBL27743650 0.77 SLC6A3 (0.43) SLC6A3HTTKDM4EPKMSLC6A2
SCHEMBL14962409 0.77 SLC6A3 (0.40) SLC6A3HTTKDM4EPKMKMT2A
SCHEMBL12180158 0.77 SLC6A3 (0.39) SLC6A3HTTADRA1AKDM4EPKM
SCHEMBL14962410 0.75 HTT (0.43) SLC6A3HTTADRA1AHTR1AADRA1D
SCHEMBL14962416 0.75 SLC6A3 (0.41) SLC6A3ADRA1AHTR1AADRA1DADRA1B
SCHEMBL9026489 0.75 SLC6A3 (0.39) SLC6A3KDM4EPKMTSHRGLS
SCHEMBL14962433 0.73 HTT (0.41) SLC6A3HTTADRA1AKDM4ESCN1A
SCHEMBL9025789 0.73 SLC6A3 (0.37) SLC6A3KDM4EPKMTSHRGLS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104418822-B Compound with xanthine oxidase inhibitory activity and application thereof 南京华威医药科技开发有限公司 2016-12-28 CN disclosed